Devices › Device types
FDA product code FRO · class U · Unknown
Dressing, wound, drug: medical device reports filed with FDA
3,166 reports carry this product code, 1992–2026; 6 brands with a page.
- 3,166
- reports with this product code
- 0% of all MAUDE reports
- 233
- reports, 12 months to August 2026
- 202 in the 12 months before
- 36.1%
- classified as malfunction
- 62.3% across all reports
- 2%
- classified as death, as reported
- 0.9% across all reports
Product code FRO is FDA's classification for "Dressing, wound, drug" (unknown panel), a class U device. 3,166 medical device reports carry this product code, 0% of the MAUDE database, from July 1992 to August 2026.
233 reports arrived in the 12 months to August 2026, up 15% from 202 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (53.3%), malfunction (36.1%) and other (7.3%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Aquacel Extra | 37 | 27 | 0% | 88.5% |
| Equate | 15 | 37 | 0.3% | 24% |
| Aquacel Foam | 11 | 124 | 0% | 88.1% |
| Unknown_Fro_Product | 2 | 7 | 0% | 36.5% |
| Duoderm/Granuflex/Duoactive - Moisture Retentive Duoderm Cgf Dressing | 1 | 0 | 0% | 99.8% |
| Medline | 1 | 26,184 | 0.1% | 97.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Convatec | 914 | 28.9% |
| Integra Neurosciences Pr | 295 | 9.3% |
| Smith & Nephew Medical | 185 | 5.8% |
| 3m Health Care | 168 | 5.3% |
| Integra Lifesciences | 102 | 3.2% |
| Convatec Dominican Republic | 87 | 2.7% |
| Smith & Nephew | 52 | 1.6% |
| B Braun Medical | 46 | 1.5% |
| 3m | 41 | 1.3% |
| Vascular Solutions | 15 | 0.5% |
| Abbott Vascular | 7 | 0.2% |
| Medline Industries | 6 | 0.2% |
| B Braun Melsungen | 3 | 0.1% |
| Stryker Leibinger Freiburg | 3 | 0.1% |
| Baxter Healthcare | 2 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Delivered as unsterile product | 454 | 14.3% |
| Insufficient device problem information | 350 | 11.1% |
| Unsealed device packaging | 226 | 7.1% |
| Contamination /decontamination problem | 194 | 6.1% |
| Patient-device incompatibilitythe device did not suit the patient | 175 | 5.5% |
| Device contamination with chemical or other material | 128 | 4% |
| Device operates differently than expectedthe device behaved unexpectedly | 117 | 3.7% |
| Contamination | 110 | 3.5% |
| Device contaminated during manufacture or shipping | 110 | 3.5% |
| Difficult to removethe device was hard to remove | 81 | 2.6% |
| Packaging problem | 80 | 2.5% |
| Improper or incorrect procedure or method | 79 | 2.5% |
| Patient device interaction problem | 60 | 1.9% |
| Dislodged | 45 | 1.4% |
| Loose | 34 | 1.1% |
| Other (for use when an appropriate device code cannot be identified) | 33 | 1% |
| Device damaged prior to usethe device was damaged before use | 29 | 0.9% |
| Device packaging compromised | 29 | 0.9% |
| Sticking | 29 | 0.9% |
| Device, removal of (non-implant) | 28 | 0.9% |
Questions about dressing, wound, drug reports
What is product code FRO?
FDA's classification code for "Dressing, wound, drug", class U, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,166 reports through August 2026, 233 of them in the latest 12 months.
Which brands appear most often?
Aquacel Extra (37), Equate (15), Aquacel Foam (11), Unknown_Fro_Product (2) and Duoderm/Granuflex/Duoactive - Moisture Retentive Duoderm Cgf Dressing (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.